Position in NVS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$136,222,908
+$3,777,128 QoQ
Shares Held
891,803
-7.2% QoQ
Ownership
0.047%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026VAN ECK ASSOCIATES CORP holds $2,742,510,249 across 15 Drug Manufacturers - General names. NVS ranks #8 (5.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMY |
Bristol Myers Squibb Co
|
10,257,215 | $622,100,088 | |
| 2 | PFE |
Pfizer Inc
|
16,301,030 | $457,732,922 | |
| 3 | LLY |
ELI LILLY & Co
|
439,012 | $403,790,067 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,792,705 | $215,644,484 | |
| 5 | BIIB |
Biogen Inc.
|
1,079,861 | $197,970,916 | |
| 6 | JNJ |
Johnson & Johnson
|
736,828 | $180,110,235 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
1,204,597 | $167,884,683 | |
| 8 | NVS |
Novartis AG
This page
|
891,803 | $136,222,908 |
All Filings in NVS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $136,222,908 | 891,803 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $132,445,780 | 960,657 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $57,022,941 | 444,658 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $48,341,679 | 399,485 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $36,050,290 | 323,379 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $31,880,118 | 327,614 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $35,738,209 | 310,713 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $30,510,371 | 286,590 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $26,159,661 | 270,440 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $21,738,639 | 215,298 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $22,420,302 | 220,109 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $19,259,379 | 190,857 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $19,759,484 | 214,777 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $28,817,661 | 317,655 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $25,859,742 | 340,215 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $29,011,034 | 343,204 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $19,265,951 | 219,555 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $19,038,282 | 217,655 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $15,520,290 | 189,781 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $11,688,756 | 128,110 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $11,762,731 | 137,608 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $12,981,575 | 137,473 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $11,644,465 | 133,906 | Shares | Sole | 2020-12-04 | |
| 2020-06-30 | $11,708,276 | 134,054 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $9,336,390 | 113,237 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||